Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Certfified Pharmacy Executive Leader (CPEL)

Integrated Informatics Institute

109 Views

Resident Posters

(12-262) Percentage of Patients with Type II Diabetes Mellitus and Cardiovascular Disease Prescribed a GLP-1 Agonist or SGLT2 Inhibitor with Proven Cardiovascular Benefit

Wednesday, December 6, 2023

2:00 PM - 3:00 PM

Location: Hall E, Lower Level

Co-Author(s): Kendall Kooser, Melanie Hyrb, Nancy Kablack, Brittany Nolton

Primary Author(s)